Click here to get full coverage on New bipolar trial scans how lithium reaches the brain at Mass General - Stock Titan

New bipolar trial scans how lithium reaches the brain at Mass General  Stock Titan

New bipolar trial scans how lithium reaches the brain at Mass General - Stock Titan

Click here to get full coverage on Alzamend Neuro Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Alzamend Neuro Disclosed Failure to Satisfy a Continued Listing Rule or Standard  TradingView

Alzamend Neuro Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Click here to get full coverage on Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency - The Globe and Mail

Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency  The Globe and Mail

Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency - The Globe and Mail

Click here to get full coverage on ALZN Jumps 14.5% With No News. Is It a Trap? - bitget.com

ALZN Jumps 14.5% With No News. Is It a Trap?  bitget.com

ALZN Jumps 14.5% With No News. Is It a Trap? - bitget.com

Click here to get full coverage on [8-K] Alzamend Neuro, Inc. Reports Material Event - Stock Titan

[8-K] Alzamend Neuro, Inc. Reports Material Event  Stock Titan

[8-K] Alzamend Neuro, Inc. Reports Material Event - Stock Titan

Click here to get full coverage on 2026: Joint Research Sharpens Understanding of Alloy Behaviour in Molten AlZn - University of Wollongong - University of Wollongong – UOW

2026: Joint Research Sharpens Understanding of Alloy Behaviour in Molten AlZn - University of Wollongong  University of Wollongong – UOW

2026: Joint Research Sharpens Understanding of Alloy Behaviour in Molten AlZn - University of Wollongong - University of Wollongong – UOW

Click here to get full coverage on EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants - Yahoo Finance

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants  Yahoo Finance

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants - Yahoo Finance

Click here to get full coverage on 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session  Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Click here to get full coverage on Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions - PR Newswire

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions  PR Newswire

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions - PR Newswire

Click here to get full coverage on Across 26 brain regions, Alzamend’s lithium drug showed higher levels - Stock Titan

Across 26 brain regions, Alzamend’s lithium drug showed higher levels  Stock Titan

Across 26 brain regions, Alzamend’s lithium drug showed higher levels - Stock Titan

Click here to get full coverage on Alzamend Neuro Mourns Loss of Director Andrew Woo - The Globe and Mail

Alzamend Neuro Mourns Loss of Director Andrew Woo  The Globe and Mail

Alzamend Neuro Mourns Loss of Director Andrew Woo - The Globe and Mail

Click here to get full coverage on Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital - PR Newswire

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital  PR Newswire

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital - PR Newswire

Click here to get full coverage on 12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session  Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Click here to get full coverage on Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March? - Yahoo Finance

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?  Yahoo Finance

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March? - Yahoo Finance

Click here to get full coverage on 10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session  Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Click here to get full coverage on Alzamend Neuro (ALZN) launches $3.0M at-the-market common stock offering - Stock Titan

Alzamend Neuro (ALZN) launches $3.0M at-the-market common stock offering  Stock Titan

Alzamend Neuro (ALZN) launches $3.0M at-the-market common stock offering - Stock Titan

Click here to get full coverage on Alzamend Neuro announces passing of board member Andrew H. Woo - investing.com

Alzamend Neuro announces passing of board member Andrew H. Woo  investing.com

Alzamend Neuro announces passing of board member Andrew H. Woo - investing.com

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Alzamend initiates phase II trial of AL001 in bipolar disorder By Investing.com - uk.investing.com

Alzamend initiates phase II trial of AL001 in bipolar disorder By Investing.com  uk.investing.com

Alzamend initiates phase II trial of AL001 in bipolar disorder By Investing.com - uk.investing.com

Click here to get full coverage on Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled - MSN

Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled  MSN

Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled - MSN

Click here to get full coverage on Major Depression Breakthrough: New Lithium Treatment Heads to Phase II at Top Hospital - Stock Titan

Major Depression Breakthrough: New Lithium Treatment Heads to Phase II at Top Hospital  Stock Titan

Major Depression Breakthrough: New Lithium Treatment Heads to Phase II at Top Hospital - Stock Titan

Click here to get full coverage on Alzamend Neuro, Inc. Receives Nasdaq Delisting Notice: SEC Form 8-K Filing March 2026 - Minichart

Alzamend Neuro, Inc. Receives Nasdaq Delisting Notice: SEC Form 8-K Filing March 2026  Minichart

Alzamend Neuro, Inc. Receives Nasdaq Delisting Notice: SEC Form 8-K Filing March 2026 - Minichart

Click here to get full coverage on What is the current Price Target and Forecast for Alzamend Neuro (ALZN) - Zacks Investment Research

What is the current Price Target and Forecast for Alzamend Neuro (ALZN)  Zacks Investment Research

What is the current Price Target and Forecast for Alzamend Neuro (ALZN) - Zacks Investment Research

Click here to get full coverage on Groundbreaking Brain Imaging Technology Could Revolutionize Lithium Treatment for Mental Health - Here's How - Stock Titan

Groundbreaking Brain Imaging Technology Could Revolutionize Lithium Treatment for Mental Health - Here's How  Stock Titan

Groundbreaking Brain Imaging Technology Could Revolutionize Lithium Treatment for Mental Health - Here's How - Stock Titan

Click here to get full coverage on ALZN Stock Price and Chart — NASDAQ:ALZN - TradingView

ALZN Stock Price and Chart — NASDAQ:ALZN  TradingView

ALZN Stock Price and Chart — NASDAQ:ALZN - TradingView

Click here to get full coverage on Should I buy Alzamend Neuro (ALZN) - Zacks Investment Research

Should I buy Alzamend Neuro (ALZN)  Zacks Investment Research

Should I buy Alzamend Neuro (ALZN) - Zacks Investment Research

Click here to get full coverage on ALZN Stock Price, Quote & Chart | ALZAMEND NEURO INC (NASDAQ:ALZN) - ChartMill

ALZN Stock Price, Quote & Chart | ALZAMEND NEURO INC (NASDAQ:ALZN)  ChartMill

ALZN Stock Price, Quote & Chart | ALZAMEND NEURO INC (NASDAQ:ALZN) - ChartMill

Click here to get full coverage on ALZN Forecast — Price Target — Prediction for 2027 - TradingView

ALZN Forecast — Price Target — Prediction for 2027  TradingView

ALZN Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on ALZN IPO News - Preclinical Alzheimer's biotech Alzamend Neuro files for a $12 million IPO - renaissancecapital.com

ALZN IPO News - Preclinical Alzheimer's biotech Alzamend Neuro files for a $12 million IPO  renaissancecapital.com

ALZN IPO News - Preclinical Alzheimer's biotech Alzamend Neuro files for a $12 million IPO - renaissancecapital.com

Click here to get full coverage on Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million - Investing News Network

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million  Investing News Network

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million - Investing News Network

Click here to get full coverage on Alzamend Neuro To Carry Out 1-for-10 Reverse Stock Split On July 16th, 2024 - Moomoo

Alzamend Neuro To Carry Out 1-for-10 Reverse Stock Split On July 16th, 2024  Moomoo

Alzamend Neuro To Carry Out 1-for-10 Reverse Stock Split On July 16th, 2024 - Moomoo

Click here to get full coverage on AlZn alloy from Rusal promises up to 15% weight reduction in automotive wheels and suspension parts - alcircle

AlZn alloy from Rusal promises up to 15% weight reduction in automotive wheels and suspension parts  alcircle

AlZn alloy from Rusal promises up to 15% weight reduction in automotive wheels and suspension parts - alcircle

Click here to get full coverage on Alzheimer’s Stock Alzamend Neuro Soars 170% in Week’s First IPO - Barron's

Alzheimer’s Stock Alzamend Neuro Soars 170% in Week’s First IPO  Barron's

Alzheimer’s Stock Alzamend Neuro Soars 170% in Week’s First IPO - Barron's

Click here to get full coverage on Alzamend Neuro director Milton Ault buys $68 in stock By Investing.com - Investing.com India

Alzamend Neuro director Milton Ault buys $68 in stock By Investing.com  Investing.com India

Alzamend Neuro director Milton Ault buys $68 in stock By Investing.com - Investing.com India

Click here to get full coverage on Alzamend Neuro, Inc. (ALZN) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Alzamend Neuro, Inc. (ALZN) Stock Forecast & Price Prediction 2026–2030  CoinCodex

ALZN

Price Chart

Key Statistics

Technicals

About ALZN

Latest News

New bipolar trial scans how lithium reaches the brain at Mass General - Stock Titan

Alzamend Neuro Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Alzamend Neuro Receives Nasdaq Notice Over Equity Deficiency - The Globe and Mail

Advanced Charts

Top Gainers

Top Losers